Lactose Intolerance Treatment Market Report: Industry Size, Market Share, Key Trends, Growth Drivers, Competitive Insights & Forecast

The new report published by The Business Research Company, titled "Lactose Intolerance Treatment Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the lactose intolerance treatment market size has grown strongly in recent years. It will grow from $30.52 billion in 2023 to $32.78 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The lactose intolerance treatment market size is expected to see strong growth in the next few years. It will grow to $43.59 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=9478&type=smp

Increasing Incidences Of Small Intestine Diseases Drives The Market
The increasing incidences of small intestine diseases are expected to propel the growth of the lactose intolerance treatment market going forward. The small intestine disease affects the body's digestive system and results in two conditions that are characterized by persistent gastrointestinal tract inflammation. Small intestine disorders are treated with lactose intolerance treatment. It contains lactose, which is broken down by the enzyme lactase into the simpler sugar glucose and galactose in the small intestine. For instance, in October 2022, according to a report by the United European Gastroenterology (UEG), an Austria-based non-profit organization, throughout Europe, more than 300 million people suffer from digestive illnesses. The cost of digestive diseases as a percentage of GDP was 0.12%, which translates to a potential cost of $20 billion in Europe in 2021, and the estimated cost of preventing productivity losses in 2019 was $11.4 billion. In the future, this will increase to $34.2 billion for 75% reductions. Therefore, increasing incidences of small intestine diseases are driving the growth of the lactose intolerance treatment market.

Technological Advancement Transforms The Market
Technological advancement is a key trend gaining popularity in the lactose intolerance treatment market. Major companies operating in lactose intolerance treatment market are focused on developing techological solutions to strengthen their position in the market. For instance, in July 2023, Nestlé, a Swiss multinational food and drink processing conglomerate corporation, has introduced a versatile and cost-effective sugar reduction technology that can be applied across different product categories, with benefits beyond sugar reduction. It can also be used to produce low lactose and skimmed milk-based products, while reducing total sugars.

The lactose intolerance treatment market covered in this report is segmented -

1) By Treatment: Food Supplements, Enzyme Lactase Supplements, Probiotics, Other Treatments
2) By Intolerance Type: Primary Lactose Intolerance, Secondary Lactose Intolerance, Congenital Lactose Intolerance, Developmental Lactose Intolerance
3) By Route of Administration: Oral, Injectable
4) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=9478&type=discount

Major companies operating in the lactose intolerance treatment market report are Johnson & Johnson Services Inc., Abbott Laboratories Inc., Macleods Pharmaceuticals Limited, Nature's Way Brands LLC, Profarma, Ganeden Inc., Deerland Probiotics & Enzymes Inc., Novozymes A/S, Cargill Incorporated, Dean Foods Company, Lupin Pharmaceuticals Inc., Nestlé S.A., Alembic Pharmaceuticals Limited, Glenmark Pharmaceuticals Limited, Intas Pharmaceuticals Ltd., Jubilant Life Sciences Limited, Wockhardt Ltd., Alkem Laboratories Limited, Teva Pharmaceutical Industries Ltd., Mylan N.V., Dr. Reddy's Laboratories Ltd., Torrent Pharmaceuticals Ltd., Amgen Inc., DuPont Nutrition & Biosciences Inc., Kerry Group plc, Koninklijke DSM N.V., Solvay S.A., Chr. Hansen Holding A/S, Bio-Cat Inc., Solgar Inc. .

Contents of the report:
1. Executive Summary
2. Lactose Intolerance Treatment Market Report Structure
3. Lactose Intolerance Treatment Market Trends And Strategies
4. Lactose Intolerance Treatment Market - Macro Economic Scenario
5. Lactose Intolerance Treatment Market Size And Growth
…..
27. Lactose Intolerance Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/lactose-intolerance-treatment-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.